Trump Advises Against Tylenol for Pregnant Women, Citing Autism Risks
President Trump has advised against using Tylenol (acetaminophen) for pregnant women and babies due to potential autism risks. The FDA and HHS have issued cautionary statements, with the FDA set to update Tylenol's label and send letters to physicians. President Trump's statement, while alarming, was more stringent than the official stance of the Health and Human Services (HHS) and the Food and Drug Administration (FDA). HHS advises against excessive use and consulting a physician before taking Tylenol. The FDA will update the label and communicate with healthcare providers. Jeremy Nighohossian, a Senior Fellow and Economist at the Competitive Enterprise Institute, echoed the advice to consult healthcare professionals for health and medication guidance. The head of the US agency that recommended caution on acetaminophen use during pregnancy, Robert F. Kennedy Jr., has made controversial statements on the topic, which are not widely accepted due to lack of scientific evidence. While President Trump's advice on Tylenol has raised concerns, the FDA and HHS have issued more nuanced guidance. It is crucial to consult healthcare professionals for personalized advice on medication use during pregnancy.
Read also:
- EU Faces Demand from Protesters to Halts Incineration of American-Owned Birth Control Products
- MERS (Middle East Respiratory Syndrome): A Comprehensive Overview and Treatment Guide
- Strategies to Maintain Optimal Eye Health Throughout Aging Process
- Hearings on the HHS Budget Detail a Fresh Approach for Public Healthcare Policies
